Reaction Details Report a problem with these data
Target
Arginase-1
Ligand
BDBM50561039
Substrate
n/a
Meas. Tech.
ChEMBL_2074195 (CHEMBL4729729)
IC50
3.0±n/a nM
Citation
 Borek, B; Gajda, T; Golebiowski, A; Blaszczyk, R Boronic acid-based arginase inhibitors in cancer immunotherapy. Bioorg Med Chem 28:0 (2020) [PubMed]  Article 
Target
Name:
Arginase-1
Synonyms:
Liver-type arginase | Type I arginase | ARGI1_HUMAN | ARG1
Type:
PROTEIN
Mol. Mass.:
34737.53
Organism:
Human
Description:
ChEMBL_978893
Residue:
322
Sequence:
MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK
  
Inhibitor
Name:
BDBM50561039
Synonyms:
CHEMBL4749355 | US11420984, Example 23
Type:
Small organic molecule
Emp. Form.:
C10H21BN2O4
Mol. Mass.:
244.10
SMILES:
CN[C@H]1CN[C@](CCCCB(O)O)(C1)C(O)=O |r|
Structure:
Search PDB for entries with ligand similarity: